ArticleBMC cancer2025

E2F2(E2F transcription factor 2) as a potential therapeutic target in meibomian gland carcinoma: evidence from functional and epigenetic studies.

Wei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.